Ainos, Inc. (OTCMKTS:AIMD – Get Free Report) shares traded down 1% during mid-day trading on Monday . The stock traded as low as $2.02 and last traded at $2.08. 6,450 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 703,132 shares. The stock had previously closed at $2.10.
Ainos Trading Down 1.0%
The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.45 and a current ratio of 1.92. The stock has a market capitalization of $10.01 million, a price-to-earnings ratio of -2.39 and a beta of 2.22. The business has a fifty day simple moving average of $3.18 and a 200 day simple moving average of $2.63.
About Ainos
Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.
See Also
- Five stocks we like better than Ainos
- 5 discounted opportunities for dividend growth investors
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- Quiet Period Expirations Explained
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- Dividend Capture Strategy: What You Need to Know
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for Ainos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ainos and related companies with MarketBeat.com's FREE daily email newsletter.
